Troy Edward Wilson

President and CEO at Kura Oncology Inc.

Sits on 3 boards. Last updated September 27, 2026

Time on boards

Boards served
3
Current seats
3
Board service
8 years
Director since
2023

8 years of board service in total across 3 boards, counting each seat separately. Longest: Kura Oncology Inc., 3 years.

Kura Oncology Inc. Director ยท President and CEO
3 years ยท Since 2023
3 years ยท Since 2023
7 months ยท Since 2026

Chief executive roles

Kura Oncology Inc. ยท President and CEO
Dates unknown

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Sep 14, 2026 Puma Biotechnology Inc Open-market sale โˆ’5,000 $9.10 $45,500
Aug 24, 2026 Kura Oncology Inc. Open-market purchase +100,000 $12.39 $1,239,000
Aug 17, 2026 Kura Oncology Inc. Open-market purchase +100,000 $11.12 $1,112,000
Jun 12, 2026 Puma Biotechnology Inc Open-market sale โˆ’10,800 $7.20 $77,760
Jun 11, 2026 Puma Biotechnology Inc Grant or award +27,000 โ€” โ€”
Mar 23, 2026 Kura Oncology Inc. Option exercise +6,103 $6.15 $37,533
Nov 13, 2025 Kura Oncology Inc. Grant or award +182,500 โ€” โ€”
Sep 29, 2025 Kura Oncology Inc. Open-market sale โˆ’36,615 $8.94 $327,338
Sep 27, 2025 Kura Oncology Inc. Grant or award +182,500 โ€” โ€”
Sep 8, 2025 Kura Oncology Inc. Open-market purchase +50,000 $8.20 $410,000
Aug 13, 2025 Kura Oncology Inc. Open-market purchase +13,494 $6.64 $89,600
Aug 12, 2025 Kura Oncology Inc. Open-market purchase +36,506 $5.85 $213,560
Jun 13, 2025 Puma Biotechnology Inc Open-market sale โˆ’10,800 $3.40 $36,720
Jun 11, 2025 Puma Biotechnology Inc Grant or award +27,000 โ€” โ€”
Jun 18, 2024 Puma Biotechnology Inc Grant or award +27,000 โ€” โ€”

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.